Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

1.

Cancer therapy with phytochemicals: evidence from clinical studies.

Hosseini A, Ghorbani A.

Avicenna J Phytomed. 2015 Mar-Apr;5(2):84-97. Review.

2.

Triterpenoids amplify anti-tumoral effects of mistletoe extracts on murine B16.f10 melanoma in vivo.

Strüh CM, Jäger S, Kersten A, Schempp CM, Scheffler A, Martin SF.

PLoS One. 2013 Apr 17;8(4):e62168. doi: 10.1371/journal.pone.0062168. Print 2013.

3.

Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach.

Davar D, Tarhini AA, Kirkwood JM.

Clin Dermatol. 2013 May-Jun;31(3):237-50. doi: 10.1016/j.clindermatol.2012.08.012. Review. Erratum in: Clin Dermatol. 2013 Jul-Aug;31(4):501.

4.

Adjuvant therapy for melanoma.

Davar D, Tarhini AA, Kirkwood JM.

Cancer J. 2012 Mar-Apr;18(2):192-202. doi: 10.1097/PPO.0b013e31824f118b. Review.

5.

Adjuvant therapy: melanoma.

Davar D, Tarhini A, Kirkwood JM.

J Skin Cancer. 2011;2011:274382. doi: 10.1155/2011/274382. Epub 2011 Dec 19.

6.

Interferon lambda: a new sword in cancer immunotherapy.

Lasfar A, Abushahba W, Balan M, Cohen-Solal KA.

Clin Dev Immunol. 2011;2011:349575. doi: 10.1155/2011/349575. Epub 2011 Dec 6. Review.

7.

Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.

Dengel LT, Norrod AG, Gregory BL, Clancy-Thompson E, Burdick MD, Strieter RM, Slingluff CL Jr, Mullins DW.

J Immunother. 2010 Nov-Dec;33(9):965-74. doi: 10.1097/CJI.0b013e3181fb045d.

8.

Clinical and immunologic basis of interferon therapy in melanoma.

Tarhini AA, Kirkwood JM.

Ann N Y Acad Sci. 2009 Dec;1182:47-57. doi: 10.1111/j.1749-6632.2009.05073.x. Erratum in: Ann N Y Acad Sci. 2012 Sep;1267:117.

9.

Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review.

Ostermann T, Raak C, Büssing A.

BMC Cancer. 2009 Dec 18;9:451. doi: 10.1186/1471-2407-9-451.

10.

Malignant melanoma (non-metastatic).

Savage P.

BMJ Clin Evid. 2007 Jun 1;2007. pii: 1705. Review.

11.

Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?

Ziegler R.

Evid Based Complement Alternat Med. 2009 Mar;6(1):19-30. doi: 10.1093/ecam/nem121. Epub 2007 Oct 4.

12.

Adjuvant therapy of melanoma with interferon: lessons of the past decade.

Ascierto PA, Kirkwood JM.

J Transl Med. 2008 Oct 27;6:62. doi: 10.1186/1479-5876-6-62. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk